Yale School of Medicine has established a research center, the Yale Center for the Science of Cannabis and Cannabinoids, to investigate how cannabis and cannabinoids affect neurodevelopment and mental health. Led by Dr. Deepak Cyril D’Souza, an expert in cannabinoid pharmacology, the center will use a multidisciplinary approach to study the acute and chronic effects…
Unlock advanced CBD formulations with nutritional lipids
Cannabidiol (CBD) is fast emerging as an exciting ingredient across the pharmaceutical market, powered by increasing scientific research investigating its potential benefits in a number of disease states, including central nervous system (CNS) disorders, pain management, cancer and more. While there is a remarkable opportunity for the development of CBD-based solutions in the field, formulation…
Preclinical cannabinoid-based study found some benefits for autism spectrum disorder
A preclinical study published in Nature indicates that cannabidiol (CBD)-enriched medical cannabis therapy may potentially bode well for autism spectrum disorder (ASD). Researchers at Tel Aviv University determined that CBD-enriched cannabis therapy improved “repetitive and anxiety behaviors, but not social deficits” in mice with the autism-associated InsG3680 Shank3 mutation. The scientists also found that the treatment led…